M R Parkhurst

Author PubWeight™ 24.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.	Nat Med	1998	11.03
2	gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.	J Exp Med	1998	5.24
3	Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.	J Exp Med	1996	1.86
4	Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.	J Immunol	1998	1.24
5	MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.	Cancer Res	1999	1.20
6	Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.	Cancer Res	1999	1.10
7	Three-dimensional cell cultures mimic tissues.	Ann N Y Acad Sci	1992	0.98
8	Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.	J Immunother	2001	0.81
9	Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells.	Dev Biol (Basel)	2004	0.80
10	Antibodies to CD18 influence neutrophil migration through extracellular matrix.	J Leukoc Biol	1999	0.77